Sigma Ends Boots Bid as $10 Billion Pharmacy Deal Falls Apart
Sigma Healthcare has ended talks to buy Boots, walking away from a deal valued at about $10 billion and leaving the future of the U.K. pharmacy chain uncertain.
The ultimate online hub for entrepreneurs, startups and companies looking for information.
Sigma Healthcare has ended talks to buy Boots, walking away from a deal valued at about $10 billion and leaving the future of the U.K. pharmacy chain uncertain.
Key Highlights Introduction Orla Mining delivered a strong update that excited investors. The company reported record gold production for 2025. At the same time, it advanced its South Railroad Gold Project into execution. As a result, Orla Mining shares jumped 11.5%. Investors responded to clearer growth visibility and rising production expectations. Record Gold Production Sets…
Australia’s Syrah Resources extended its graphite supply deadline with Tesla to March 2026, buying time to resolve technical issues at its Louisiana facility and protect a key U.S. battery supply deal.